Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

Kaiser Daily Global Health Policy ReportIntellectual Property and Trade Search Results « » The Henry J. Kaiser Family Foundation

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results



  • results
POLITICO Examines Leaked Draft Copy Of TPP’s Intellectual Property Chapter, Pharmaceutical Implications

POLITICO: Leaked: What’s in Obama’s trade deal “A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law. POLITICO has obtained a draft copy of TPP’s intellectual property chapter as it…

Developing Nations Must Undergo Tax Reforms To Finance SDGs

The Guardian: Why developing countries need to toughen up on taxes Lilianne Ploumen, Dutch minister for foreign trade and development cooperation “Next week, the U.N. financing conference in Addis Ababa will make decisions that will have a profound impact on the global community over the next 15 years and beyond.…

Food Security, Nutrition Should Be Treated As Human Right In SDGs

The Guardian: Why are there still so many hungry people in the world? Hilal Elver, U.N. special rapporteur on the right to food “…The new [Sustainable Development Goals] should not be allowed to operate as easily ignored principles, but need to be given teeth. We can eradicate poverty, maintain food…

Pharmaceutical Industry To Push For Stricter Compulsory Licensing Of Patented Drugs At U.S. Trade Representative Meeting

Wall Street Journal: Pharma Narrowly Defines When Compulsory Licenses Should be Used “As the U.S. Trade Representative holds a hearing [Tuesday] to discuss how countries protect intellectual property, the pharmaceutical industry hopes to persuade the agency that countries should only be allowed to grant licenses to companies to make low-cost…

TPP Would Limit Countries’ Abilities To Make, Purchase Low-Cost Generic Medicines

Huffington Post: TPP: Still a Terrible Deal for Poor People’s Health Manica Balasegaram, executive director of Médecins Sans Frontières’ Access Campaign “…The ability to manufacture and/or purchase low-cost generic medicines requires maintaining a balance in a country’s patent system between monopoly protection and public health. Yet, the [Trans-Pacific Partnership (TPP)]…